DrugPatentWatch Database Preview

Sugammadex sodium - Generic Drug Details

What are the generic sources for sugammadex sodium and what is the scope of sugammadex sodium freedom to operate?

Sugammadex sodium is the generic ingredient in one branded drug marketed by Organon Sub Merck and is included in one NDA. There are three patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Sugammadex sodium has fifty-five patent family members in thirty countries.

There are two drug master file entries for sugammadex sodium. One supplier is listed for this compound.

Summary for sugammadex sodium

International Patents:	55
US Patents:	3
Tradenames:	1
Applicants:	1
NDAs:	1
Drug Master File Entries:	2
Suppliers / Packagers:	1
Bulk Api Vendors:	9
Clinical Trials:	5
Formulation / Manufacturing:	see details
DailyMed Link:	sugammadex sodium at DailyMed

Pharmacology for sugammadex sodium

Synonyms for sugammadex sodium

1202253-72-2
343306-71-8
343306-79-6
361LPM2T56
862667-16-1
AC-30384
Bridion
Bridion (TN)
CHEBI:90952
CHEBI:90953
D05940
DB06206
ERJ6X2MXV7
EX-A2600
gamma-Cyclodextrin, 6A,6B,6C,6D,6E,7F,6G,6H-octakis-S-(2-carboxyethyl)-6A,6B,6C,6D,6E,7F,6G,6H-octathio-, octasodium salt
MK-8616
Octasodium 6,6',6'',6''',6'''',6''''',6'''''',6'''''''-octakis-S-(2-carboxylatoethyl)-6,6',6'',6''',6'''',6''''',6'''''',6'''''''-octathiocyclo-alpha-(1-4)-D-octaglucopyranoside
Org 25969
ORG-25969
SCH-900616
SCHEMBL13917069
Sugammadex
Sugammadex [USAN:INN:BAN]
Sugammadex sodium (JAN/USAN)
Sugammadex sodium [USAN:JAN]
UNII-361LPM2T56
UNII-ERJ6X2MXV7

US Patents and Regulatory Information for sugammadex sodium

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Organon Sub Merck	BRIDION	sugammadex sodium	SOLUTION;INTRAVENOUS	022225-001	Dec 15, 2015		RX	Yes	Yes	➤ Sign Up	➤ Sign Up				➤ Sign Up
Organon Sub Merck	BRIDION	sugammadex sodium	SOLUTION;INTRAVENOUS	022225-002	Dec 15, 2015		RX	Yes	No	➤ Sign Up	➤ Sign Up				➤ Sign Up
Organon Sub Merck	BRIDION	sugammadex sodium	SOLUTION;INTRAVENOUS	022225-002	Dec 15, 2015		RX	Yes	No	➤ Sign Up	➤ Sign Up				➤ Sign Up
Organon Sub Merck	BRIDION	sugammadex sodium	SOLUTION;INTRAVENOUS	022225-002	Dec 15, 2015		RX	Yes	No	➤ Sign Up	➤ Sign Up				➤ Sign Up
Organon Sub Merck	BRIDION	sugammadex sodium	SOLUTION;INTRAVENOUS	022225-001	Dec 15, 2015		RX	Yes	Yes	➤ Sign Up	➤ Sign Up	Y	Y		➤ Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration

International Patents for sugammadex sodium

Subscribe to access the full database, or try a Free Trial
Country	Patent Number	Estimated Expiration
Colombia	5251450	➤ Sign Up
Japan	4563972	➤ Sign Up
Hungary	0203755	➤ Sign Up
Canada	2380920	➤ Sign Up
Japan	4782334	➤ Sign Up
Country	Patent Number	Estimated Expiration

Supplementary Protection Certificates for sugammadex sodium

Subscribe to access the full database, or try a Free Trial
Patent Number	Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
1259550	122008000068	Germany	➤ Sign Up	PRODUCT NAME: SUGAMMADEX ODER EIN PHARMAZEUTISCH VERTRAEGLICHES SALZ DAVON; REGISTRATION NO/DATE: EU/1/08/466/001-002 20080725
1259550	08C0052	France	➤ Sign Up	PRODUCT NAME: SUGAMMADEX SODIUM; REGISTRATION NO/DATE: EU/1/08/466/001-002 20080725
1259550	2008C/047	Belgium	➤ Sign Up	PRODUCT NAME: SUGAMMADEX SODIQUE; AUTHORISATION NUMBER AND DATE: EU/1/08/466001 20080729
1259550	91501	Luxembourg	➤ Sign Up	91501, EXPIRES: 20230725
1259550	300356	Netherlands	➤ Sign Up
Patent Number	Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description